ICON Public Limited Company (ICLR)Healthcare | Diagnostics & Research | Dublin, Ireland | NasdaqGS
170.02 USD
+0.30
(0.177%)
⇧
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 170.02 |
Hot Take ↕ | Aug. 22, 2026, 6:07 a.m. EDT
ICON (ICLR) is a high-volatility turnaround candidate where the market is aggressively pricing in a recovery despite deteriorating quarterly results. The nine-year price history shows a robust 130% gain, yet the most recent annual return was a steep 45% decline, mirroring the 63% contraction in earnings growth. While the forward P/E of 14.5x offers a compelling valuation if profitability returns, the current return on equity of 0.28% and sub-1.0 current ratio highlight significant operational fragility. Short-term momentum is strong, with shares surging 10% in the last fortnight and trading above key moving averages, supported by bullish options flow. However, the balance sheet lacks the fortress-like strength required for a top-tier long-term hold, making this a speculative wager on management's ability to fix margins rather than a certainty of compounding returns. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.040100 |
| AutoARIMA | 0.047655 |
| AutoETS | 0.047657 |
| AutoTheta | 0.071295 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 50% |
| H-stat | 0.77 |
| Ljung-Box p | 0.048 |
| Jarque-Bera p | 0.566 |
| Excess Kurtosis | 0.56 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 37.596 |
| Revenue per Share | 107.957 |
| Market Cap | 13,117,758,464 |
| Trailing P/E | 261.57 |
| Forward P/E | 14.31 |
| Beta | 1.20 |
| Profit Margins | 0.33% |
| Website | https://www.iconplc.com |
As of Aug. 22, 2026, 6:07 a.m. EDT: Implied volatility is elevated across expirations (50-60%), reflecting uncertainty ahead of earnings. Call volume significantly exceeds put volume in total exp volume, with notable interest at 210-strike calls for September and 120-strike calls for December, signaling speculative upside bets. However, substantial put open interest at lower strikes (65-90) acts as a hedge against downside risk, creating a volatile environment where traders are betting on a rebound while protecting against further declines.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.045659006 |
| Address1 | South County Business Park |
| Address2 | Leopardstown |
| All Time High | 347.72 |
| All Time Low | 2.5 |
| Ask | 214.02 |
| Ask Size | 2 |
| Average Analyst Rating | 1.9 - Buy |
| Average Daily Volume10 Day | 462,190 |
| Average Daily Volume3 Month | 866,982 |
| Average Volume | 866,982 |
| Average Volume10Days | 462,190 |
| Beta | 1.203 |
| Bid | 121.68 |
| Bid Size | 2 |
| Book Value | 121.551 |
| City | Dublin |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Ireland |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 170.02 |
| Current Ratio | 0.953 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 170.42 |
| Day Low | 165.7 |
| Debt To Equity | 37.596 |
| Earnings Call Timestamp End | 1,785,412,800 |
| Earnings Call Timestamp Start | 1,785,412,800 |
| Earnings Growth | -0.633 |
| Earnings Quarterly Growth | -0.643 |
| Earnings Timestamp | 1,785,355,200 |
| Earnings Timestamp End | 1,792,612,800 |
| Earnings Timestamp Start | 1,792,612,800 |
| Ebitda | 523,480,992 |
| Ebitda Margins | 0.06311 |
| Enterprise To Ebitda | 30.021 |
| Enterprise To Revenue | 1.895 |
| Enterprise Value | 15,715,208,192 |
| Eps Current Year | 10.58905 |
| Eps Forward | 11.87756 |
| Eps Trailing Twelve Months | 0.65 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 353 1 247 6260 |
| Fifty Day Average | 166.1422 |
| Fifty Day Average Change | 3.8778076 |
| Fifty Day Average Change Percent | 0.023340294 |
| Fifty Two Week Change Percent | -4.565901 |
| Fifty Two Week High | 203.91 |
| Fifty Two Week High Change | -33.89 |
| Fifty Two Week High Change Percent | -0.16620077 |
| Fifty Two Week Low | 66.57 |
| Fifty Two Week Low Change | 103.450005 |
| Fifty Two Week Low Change Percent | 1.5540034 |
| Fifty Two Week Range | 66.57 - 203.91 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 895,239,000,000 |
| Float Shares | 77,097,886 |
| Forward Eps | 11.87756 |
| Forward P E | 14.314388 |
| Free Cashflow | 622,646,656 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 40,200 |
| Fullday Change | 0.300003 |
| Fullday Change Percent | 0.176764 |
| Fullday Price | 170.02 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.23909001 |
| Gross Profits | 1,983,081,984 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0044400003 |
| Held Percent Institutions | 1.0835 |
| Implied Shares Outstanding | 77,154,209 |
| Industry | Diagnostics & Research |
| Industry Disp | Diagnostics & Research |
| Industry Key | diagnostics-research |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,218,585,600 |
| Last Split Factor | 2:1 |
| Long Business Summary | ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, contract staffing, data solutions, and laboratory services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers testing services comprising bioanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, medical imaging, real world intelligence, site and patient, and strategic solutions. Additionally, it provides therapeutics for cardiovascular, central nervous system, endocrine and metabolic disorders, hepatology, infectious diseases, internal medicine immunology, and oncology. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland. |
| Long Name | ICON Public Limited Company |
| Market | us_market |
| Market Cap | 13,117,758,464 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_397809 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | 27,043,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 13,093,455,038 |
| Number Of Analyst Opinions | 16 |
| Open | 167.65 |
| Operating Cashflow | 1,112,029,056 |
| Operating Margins | 0.094119996 |
| Payout Ratio | 0.0 |
| Peg Ratio | 0.55 |
| Phone | 353 1 291 2000 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 170.02 |
| Post Market Time | 1,787,959,806 |
| Previous Close | 169.72 |
| Price Eps Current Year | 16.05621 |
| Price Hint | 2 |
| Price To Book | 1.3987545 |
| Price To Sales Trailing12 Months | 1.5815166 |
| Profit Margins | 0.0032600001 |
| Quick Ratio | 0.924 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 1.94118 |
| Region | US |
| Regular Market Change | 0.300003 |
| Regular Market Change Percent | 0.176764 |
| Regular Market Day High | 170.42 |
| Regular Market Day Low | 165.7 |
| Regular Market Day Range | 165.7 - 170.42 |
| Regular Market Open | 167.65 |
| Regular Market Previous Close | 169.72 |
| Regular Market Price | 170.02 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 314,629 |
| Return On Assets | 0.00969 |
| Return On Equity | 0.0028600001 |
| Revenue Growth | 0.012 |
| Revenue Per Share | 107.957 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 77,154,209 |
| Shares Percent Shares Out | 0.028800001 |
| Shares Short | 2,220,474 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 2,596,851 |
| Short Name | ICON plc |
| Short Percent Of Float | 0.0325 |
| Short Ratio | 2.75 |
| Source Interval | 15 |
| Symbol | ICLR |
| Target High Price | 220.0 |
| Target Low Price | 155.0 |
| Target Mean Price | 185.5625 |
| Target Median Price | 186.5 |
| Total Cash | 928,385,024 |
| Total Cash Per Share | 12.033 |
| Total Debt | 3,525,835,008 |
| Total Revenue | 8,294,416,896 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 0.65 |
| Trailing P E | 261.56924 |
| Trailing Peg Ratio | 0.5502 |
| Triggerable | 1 |
| Two Hundred Day Average | 147.3203 |
| Two Hundred Day Average Change | 22.699707 |
| Two Hundred Day Average Change Percent | 0.15408404 |
| Type Disp | Equity |
| Volume | 314,629 |
| Website | https://www.iconplc.com |
| Zip | D18 X5R3 |